aprostx.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: Sitemap: | ||
Meta Tags
| Title | Apros |
| Description | Next generation innate immune Next generation innate immune agonists. Apros Therapeutics is a drug discovery and development company focused on tissue-targeted small molecule innate immune agonists to increase tumor immunogenicity – turning cold tumors hot. We do this utilizing |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 52.25.87.207 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
aprostx.com Valuation
|
US$1,737
Last updated: 2023-05-20 04:21:37
aprostx.com has Semrush global rank of 0. aprostx.com has an estimated worth of US$ 1,737, based on its estimated Ads revenue. aprostx.com receives approximately 200 unique visitors each day. Its web server is located in United States, with IP address 52.25.87.207. According to SiteAdvisor, aprostx.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,737 |
| Daily Ads Revenue | US$1 |
| Monthly Ads Revenue | US$48 |
| Yearly Ads Revenue | US$577 |
| Daily Unique Visitors | 13 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| aprostx.com. | A | 59 | IP: 52.25.87.207 |
| aprostx.com. | NS | 21600 | NS Record: ns-cloud-a2.googledomains.com. |
| aprostx.com. | NS | 21600 | NS Record: ns-cloud-a4.googledomains.com. |
| aprostx.com. | NS | 21600 | NS Record: ns-cloud-a3.googledomains.com. |
| aprostx.com. | NS | 21600 | NS Record: ns-cloud-a1.googledomains.com. |
| aprostx.com. | MX | 3600 | MX Record: 1 aspmx.l.google.com. |
| aprostx.com. | MX | 3600 | MX Record: 5 alt1.aspmx.l.google.com. |
| aprostx.com. | MX | 3600 | MX Record: 10 alt4.aspmx.l.google.com. |
| aprostx.com. | MX | 3600 | MX Record: 10 alt3.aspmx.l.google.com. |
| aprostx.com. | MX | 3600 | MX Record: 5 alt2.aspmx.l.google.com. |
| aprostx.com. | TXT | 3600 | TXT Record: MS=ms27308962 |
HtmlToTextCheckTime:2023-05-20 04:21:37
| home platform pipeline team news contact Next generation innate immune agonists --> Precision targeting through chemistry Delivering innate immune agonists specifically to the right tissue , for the right duration , at the right dose to fight cancer and infectious disease. TISSUE + TIME + DOSE Turning cold tumors into hot tumors using tissue-targeted innate immune agonists Apros Therapeutics is a drug discovery and development company focused on tissue-targeted small molecule innate immune agonists to increase tumor immunogenicity – turning cold tumors hot. We do this utilizing novel chemistry approaches to precisely target the agonist to certain tumors/tissues with little to no systemic distribution. Goal Strategy Tactics TLR agonist have the potential to turn immunologically cold tumors into hot tumors by increasing tumor antigenicity and promoting inflammation within the tumor microenvironment. Combining TLR agonists with checkpoint inhibitors provides complementary mechanisms |
HTTP Headers
HTTP/1.1 301 Moved Permanently Content-Length: 143 Content-Type: text/html; charset=UTF-8 Location: https://aprostx.com/ Server: Microsoft-IIS/10.0 Access-Control-Allow-Credentials: true Access-Control-Allow-Headers: Origin, X-Requested-With, Content-Type, Accept, Set-Cookie, withCredentials, Authorization Date: Sat, 07 Jan 2023 08:49:05 GMT HTTP/2 200 content-type: text/html; charset=utf-8 server: Microsoft-IIS/10.0 access-control-allow-origin: access-control-allow-credentials: true access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Set-Cookie, withCredentials, Authorization date: Sat, 07 Jan 2023 08:49:05 GMT |